Publications
Specialty
Search
Podiatry Today, Podiatry
07/01/2024
What are the differences between these professional documents, and how should physicians utilize each?
Vascular Disease Management
07/01/2024
Dr. Jordan discusses the 5-year results.
Podiatry Today
06/30/2024
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Podiatry Today
06/30/2024
The reviewers state that gout was historically described as an affliction impacting wealthy, Caucasian males. However, current research suggests otherwise.
Psych Congress Network
06/28/2024
Summertime is a great time to transition to a nonstimulant treatment for ADHD.
Psych Congress Network
06/28/2024
Listen to Megan, an adult with ADHD, and her best friend talk about her ADHD journey, including current treatment with a nonstimulant medication.
Psych Congress Network
06/28/2024
Online searches for "women ADHD" have increased 700% in the past 5 years.
Psych Congress Network
06/28/2024
Downloadable counseling resource designed to help men and women recognize ADHD symptoms that can present differently in men and women.
Psych Congress Network
06/28/2024
Transitioning patients to a once-daily nonstimulant for ADHD.
The Dermatologist, Surgery
06/28/2024
A new study highlights the effectiveness of autologous skin cell suspension transplantation in treating stable vitiligo, showing positive patient-reported outcomes and significant repigmentation improvements.
The Dermatologist
06/28/2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.
Oncology
06/28/2024
Efrat Dotan, MD, discussed results from the phase 2 GIANT study which compared gemcitabine and nab-paclitaxel to 5-fluorouracil, leucovorin, and liposomal irinotecan among older adults with treatment-naive metastatic pancreatic cancer.
Vascular Disease Management
06/28/2024
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment.
FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE) in Canada. The news comes in conjunction with Health Canada approval for this first-of-its-kind endovascular device, which is indicated to treat lesions of the descending thoracic aorta—while maintaining flow into the left subclavian artery (LSA)—in patients with appropriate anatomy.
Wound Care
06/28/2024
In this interview, Dr. Paul Kim discusses with DocNow Founder/CEO Dr. Kashif Saeed the catalyst for starting DocNow, the charting challenges in post-acute care, the technology advancements that are being made in the space, as well as the future of technology for post-acute care providers. This wide-ranging discussion covers the vision of DocNow and the mission to enhance the technology options available to post-acute care providers.
First Report Managed Care
06/28/2024
Learn about the impact of the 2024 Medicare Physician Fee Schedule, the importance of virtual care management services in chronic care, and how organizations like TimeDoc can help providers navigate the changing health care landscape.
Psych Congress Network
06/28/2024
Which factor is NOT a consideration when choosing an antidepressant medication according to the APA's major depressive disorder practice guidelines? Take the quiz to find out!
EMSWorld
06/28/2024
As part of this initiative, the emergency services in Slovak capital Bratislava and Košice are spending about €8 million ($9.5 million) to buy some 65 ambulances under several acquisitions.
Oncology
06/28/2024
True or False: As reported in the phase 3 PEARLY trial, the addition of carboplatin to standard anthracycline and taxane therapy significantly improved event-free survival among patients with early-stage triple-negative breast cancer (TNBC).
Gastroenterology
06/28/2024
The device can provide results in an hour from a fingertip blood test.
First Report Managed Care
06/28/2024
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support for patients. In this interview, Dee Chaudhary, Principal at Clarivate Commercial Strategy Consulting Group, shared findings from her session at the annual conference.